Mutation analysis of the myocyte enhancer factor 2A gene (MEF2A) in patients with left ventricular hypertrophy/hypertrophic cardiomyopathy.
Coto
Eliecer
E
Genética Molecular and Cardiología-Fundación Asturcor, Hospital Universitario Central Asturias, Oviedo, Spain. eliecer.coto@sespa.princast.es
Castro
Mónica G
MG
Corao
Ana I
AI
Alonso-Montes
Cristina
C
Reguero
Julián R
JR
Morís
César
C
Alvarez
Victoria
V
D000328:Adult; D000368:Aged; D002312:Cardiomyopathy, Hypertrophic / Q000235:genetics*; D004252:DNA Mutational Analysis; D005260:Female; D006352:Heart Ventricles / Q000473:pathology; D006801:Humans; D017379:Hypertrophy, Left Ventricular / Q000235:genetics*; D064326:MEF2 Transcription Factors; D008297:Male; D008875:Middle Aged; D009154:Mutation; D018006:Myogenic Regulatory Factors / Q000235:genetics*
D064326:MEF2 Transcription Factors; D018006:Myogenic Regulatory Factors